Delivery Order HHSD200201142027I-HHSD2002011420270003

Research Triangle Institute (RTI) International was awarded an $818,766 time and materials contract by the Department of Health and Human Services Centers for Disease Control and Prevention to develop a qualitative clinical proficiency testing program. This award calls against RTI's Achieving Public Health Impact Through Research blanket purchase agreement, a vehicle established with no set-aside designation to streamline assistance for CDC and other HHS agencies. RTI will leverage its expertise...

This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Optum Labs Topaz Inc., a for-profit organization doing business as Ingenix Public Sector Solutions. The contract, which does not have a set-aside designation, is for "Monitoring Sexually Transmitted Infections" and has a potential value of $129,309.47. The contract was awarded on September 30, 2017, with a completion date of September 29, 2021. The...

This is a $9,086,592.00 firm-fixed-price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services (HHS), to the Association of Public Health Laboratories (APHL), a non-profit organization. The contract is for the development of a system to enable voluntary public reporting of over-the-counter COVID-19 test results to federal and state public health agencies, with the goal of enhancing virus spread monitoring and...

This is a delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a leading medical diagnostics company, for COST PER TEST STD TESTING services. The $323,825.00 firm fixed-price contract has a completion date of March 11, 2016 and was not set aside for any specific business category. Gen-Probe, the prime contractor, specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government....

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Fenway Community Health Center, Inc., a non-profit organization, for $149,365.00 to provide biological specimens from HIV-positive men who are under or initiating integrase inhibitor-based antiretroviral therapy. The purpose is to develop and assess retroviral integrase, as integrase strand transfer inhibitor (INSTI)-based regimens are increasing in use and...

Boston Medical Center Corporation is providing clinical trial network services under a $678,333 delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle through the National Institutes of Health National Institute of Child Health and Human Development. As the prime contractor, BMC will support the Evaluation of LARCs Study as a clinical research site. No set-aside designation was applied to this order to evaluate long-acting reversible contraceptive methods....

The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to Fenway Community Health Center, Inc., a non-profit organization based in Boston, Massachusetts, for the LATERAL FLOW ASSAY EVALUATION project. The contract, valued at $206,209.00, does not have a set-aside designation and has an ultimate completion date of September 29, 2025. Fenway Community Health Center has experience serving as a subrecipient partner on various federal research...

Clinical Diagnostic Laboratories, LLC, doing business as Clinical Diagnostic Lab, was awarded a $3.5 million firm-fixed-price definitive contract by the Department of State Bureau of Medical Services to provide on-site biological specimen collection and reverse transcriptase polymerase chain reaction testing for SARS-CoV-2. The one-year base period contract, with four one-year options, will support testing of approximately 180 personnel annually in the Washington, D.C. area through March 2022....

The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...

This federal contract award is for HIV force testing services for the U.S. Army Medical Command (MEDCOM). The $6,303,692.40 firm fixed price delivery order was awarded to Center for Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings that specializes in infectious disease testing for government agencies. The work will be performed in San Antonio, Texas and supports the military's efforts to monitor and address HIV prevalence among service members. This award is...